B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Lindell, Dennis M ^a   Berlin, Aaron A ^a   Schaller, Matthew A ^a   Lukacs, Nicholas W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; B LYMPHOCYTE ANTIGEN; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; ANTIGEN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MOUSE; MUCUS SECRETION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION; TH2 CELL; TISSUE DISTRIBUTION; UPREGULATION; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; COCKROACH; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; LUNG DISEASE; METABOLISM; T LYMPHOCYTE; TRANSGENIC MOUSE;

MUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; B-LYMPHOCYTES; COCKROACHES; FEMALE; HUMANS; HYPERSENSITIVITY; LUNG DISEASES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES; TH2 CELLS;

EID: 51549098344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003129     Document Type: Article

References (66)

1. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, et al. (2002) Surveillance for asthma-United States, 1980-1999. MMWR Surveill Summ 51: 1-13.
2. Aberg N, Hesselmar B, Aberg B, Eriksson B (1995) Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 25: 815-819.
3. von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U (1998) Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 351: 862-866.
4. Garcia-Marcos L, Quiros AB, Hernandez GG, Guillen-Grima F, Diaz CG, et al. (2004) Stabilization of asthma prevalence among adolescents and increase among schoolchildren (ISAAC phases I and III) in Spain. Allergy 59: 1301-1307.
5. Zollner IK, Weiland SK, Piechotowski I, Gabrio T, von Mutius E, et al. (2005) No increase in the prevalence of asthma, allergies, and atopic sensitisation among children in Germany: 1992-2001. Thorax 60: 545-548.
6. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, et al. (2001) Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108: 184-190.
7. Blease K, Jakubzick C, Westwick J, Lukacs N, Kunkel SL, et al. (2001) Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 166: 5219-5224.
8. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, et al. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.
9. Kuperman DA, Huang Y, Koth LL, Chang GH, Dolganov GM, et al. (2002) Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8: 885-889.
10. Tomkinson A, Duez C, Cieslewicz G, Pratt JC, Joetham A, et al. (2001) A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents andgen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol 166: 5792-5800.
11. Tournoy KG, Kips JC, Pauwels RA (2001) The allergen-induced airway hyperresponsiveness in a human-mouse chimera model of asthma is T cell and IL-4 and IL-5 dependent. J Immunol 166: 6982-6991.
12. Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, et al. (2002) The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 26: 202-208.
13. Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, et al. (2001) Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 167: 4668-4675.
14. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, et al. (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103: 779-788.
15. Macaubas C, DeKruyff RH, Umetsu DT (2003) Respiratory tolerance in the protection against asthma. Curr Drug Targets Inflamm Allergy 2: 175-186.
16. Renz H, Herz U (2002) The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur Respir J 19: 158-171.
17. Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG (1997) Allergic cosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 185: 885-892.
18. Hamelmann E, Takeda K, Schwarze J, Vella AT, Irvin CG, et al. (1999) Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am J Respir Cell Mol Biol 21: 480-489.
19. Oshiba A, Hamelmann E, Takeda K, Bradley KI, Loader JE, et al. (1996) Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J Clin Invest 97: 1398-1408.
20. Lack G, Oshiba A, Bradley KL, Loader JE, Amran D, et al. (1995) Transfer of immediate hypersensitivity and airway hyperresponsiveness by IgE-Positive B cells. Am J Respir Crit Care Med 152: 1765-1773.
21. Haczku A, Takeda F, Redai I, Hamelmann E, Cieslewicz G, et al. (1999) Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. Am J Respir Crit Care Med 159: 1638-1643.
22. Arnaboldi PM, Behr MJ, Metzger DW (2005) Mucosal B cell deficiency in IgA-/- mice abrogates the development of allergic lung inflammation. J Immunol 175: 1276-1285.
23. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, et al. (2003) Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278: 17036-17043.
24. Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB, et al. (2005) Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol 116: 550-557.
25. Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD, et al. (2004) Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am J Respir Crit Care Med 170: 306-312.
26. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, et al. (2006) Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 203: 2715-2725.
27. Lund FE, Hollifield M, Schuer K, Lines JL, Randall TD, et al. (2006) B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol 176: 6147-6154.
28. Meinl E, Krumbholz M, Hohlfeld R (2006) B lineage cells in the inflammatory cenural nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann Neurol 59: 880-892.
29. van der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, et al. (2006) Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med 173: 751-758.
30. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653.
31. Gosman MM, Willemse BW, Jansen DF, Lapperre TS, van Schadewjk A, et al. (2006) Increased number of B-cells in bronchial biopsies in COPD. Eur Respir J 27: 60-64.
32. Martinez-Gamboa L, Brezinschek HP, Burmester GR, Dorner T (2006) Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy. Autoimmun Rev 5: 437-442.
33. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM (2001) T cell activation in rheumatoid synovium is B cell dependent. J Immunol 167: 4710-4718.
34. Linton PJ, Bautista B, Biederman E, Bradley ES, Harbertson J, et al. (2003) Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med 197: 875-883.
35. Christensen JP, Kauffmann SO, Thomsen AR (2003) Deficient CD4+ T cell priming and regression of CD8+ T cell functionality in virus-infected mice lacking a normal B cell compartment. J Immunol 171: 4733-4741.
36. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189: 1639-1648.
37. Crawford A, Macleod M, Schumacher T, Corlett L, Gray D (2006) Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immumol 176: 3498-3506.
38. Noorchashm H, Reed AJ, Rostami SY, Mozaffari R, Zekavat G, et al. (2006) B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol 177: 7715-7722.
39. Williams CM, Galli SJ (2000) Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 192: 455-462.
40. Bandukwala HS, Clay BS, Tong J, Mody PD, Cannon JL, et al. (2007) Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. J Exp Med 204: 1875-1889.
41. Kitamura K, Takeda K, Koya T, Miyahara N, Kodama T, et al. (2007) Critical role of the Fc receptor gamma-chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation. J Immunol 178: 480-488.
42. Watanabe T, Okano M, Hattori H, Yoshino T, Ohno N, et al. (2004) Roles of FcgammaRIIB in nasal eosinophilia and IgE production in murine allergic rhinitis. Am J Respir Crit Care Med 169: 105-112.
43. Harris DP, Goodrich S, Mohrs K, Mohrs M, Lund FE (2005) Cutting edge: the development of IL-4-producing B cells (B effector 2 cells) is controlled by IL-4, IL-4 receptor alpha, and Th2 cells. J Immunol 175: 7103-7107.
44. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, et al. (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 1: 475-482.
45. Zhu J, Qui Y, Valobra M, Qui S, Majumdar S, et al. (2007) Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175: 1125-1133.
46. Inoue S, Leitner WW, Golding B, Scott D (2006) Inhibitory effects of B cells on antitumor immunity. Cancer Res 66: 7741-7747.
47. Mizoguchi A, Bhan AK (2006) A case for regulatory B cells. J Immunol 176: 705-710.
48. Lundy SK, Berlin AA, Martens TF, Lukacs NW (2005) Deficiency of regulatory B cells increases allergic airway inflammation. Inflamm Res 54: 514-521.
49. Yu P, Wang Y, Chin RK, Martinez-Pomares L, Gordon S, et al. (2002) B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J Immunol 168: 5117-5123.
50. Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, et al. (2000) B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med 192: 475-482.
51. Angeli V, Ginhoux F, Llodra J, Quemencur L, Frenette PS, et al. (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24: 203-215.
52. De Bruijn ML, Nieland JD, Schumacher TN, Ploegh HL, Kast WM, et al. (1992) Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses. Eur J Immunol 22: 3013-3020.
53. Guery JC, Adorini L (1995) Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol 154: 536-544.
54. Guery JC, Ria F, Adorini L (1996) Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J Exp Med 183: 751-757.
55. Levin D, Constant S, Pasqualini T, Flavell R, Bottomly K (1993) Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. J Immunol 151: 6742-6750.
56. Masten QJ, Lipscomb MF (1999) Comparison of lung dendritic cells and B cells in stimulating naive antigen-specific T cells. J Immunol 162: 1310-1317.
57. Zhong G, Reis e Sousa C, Germain RN (1997) Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J Exp Med 186: 673-682.
58. Qi H, Egen JG, Huang AY, Germain RN (2006) Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312: 1672-1676.
59. Lanzavecchia A (1990) Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 8: 773-793.
60. Berlin AA, Hogaboam CM, Lukacs NW (2006) Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma. Lab Invest 86: 557-565.
61. Smit JJ, Boon L, Lukacs NW (2007) Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-gamma production. Am J Pathol 171: 1944-1951.
62. John AE, Gerard CJ, Schaller M, Miller AL, Berlin AA, et al. (2005) Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses. Eur J Immunol 35: 108-116.
63. Schaller MA, Kalla LE, Lukacs NW (2008) A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation. Am J Pathol 172: 386-394.
64. Lundy SK, Lira SA, Smit JJ, Cook DN, Berlin AA, et al. (2005) Attenuation of allergen-induced responses in CCR6-/- mice is dependent upon altered pulmonary T lymphocyte activation. J Immunol 174: 2054-2060.
65. Schaller MA, Lundy SK, Huffnagle GB, Lukacs NW (2005) CD8+ T cell contributions to allergen induced pulmonary inflammation and airway hyperreactivity. Eur J Immunol 35: 2061-2070.
66. Miller Al, Strieter RM, Gruber AD, Ho SB, Lukacs NW (2003) CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J Immunol 170: 3348-3356.